Literature DB >> 19332322

Commentary: the prospect of cell-based therapy for epilepsy.

Arnold R Kriegstein1, Asla Pitkänen.   

Abstract

About 30% of patient with epilepsy do not respond to available antiepileptic drugs. In addition to seizure suppression, novel approaches are needed to prevent or alleviate epileptogenic process after various types of brain injuries. The use of cell transplants as factories to produce endogeneous anticonvulsants or as bricks to repair abnormal ictogenic and epileptogenic neuronal circuits has generated hope that cell-based therapies could become a novel therapeutic category in the treatment arsenal of epilepsy. Herein we summarize the current status and future perspectives of cell-based therapies in the treatment of epilepsy.

Entities:  

Mesh:

Year:  2009        PMID: 19332322      PMCID: PMC5084206          DOI: 10.1016/j.nurt.2009.01.013

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  37 in total

1.  Conditionally immortalized cell lines, engineered to produce and release GABA, modulate the development of behavioral seizures.

Authors:  K Thompson; V Anantharam; S Behrstock; E Bongarzone; A Campagnoni; A J Tobin
Journal:  Exp Neurol       Date:  2000-02       Impact factor: 5.330

2.  Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.

Authors:  Manuel Alvarez-Dolado; Maria Elisa Calcagnotto; Kameel M Karkar; Derek G Southwell; Dorothy M Jones-Davis; Rosanne C Estrada; John L R Rubenstein; Arturo Alvarez-Buylla; Scott C Baraban
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

3.  Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra.

Authors:  W Löscher; U Ebert; H Lehmann; C Rosenthal; G Nikkhah
Journal:  J Neurosci Res       Date:  1998-01-15       Impact factor: 4.164

4.  Status epilepticus causes selective regional damage and loss of GABAergic neurons in the rat amygdaloid complex.

Authors:  J Tuunanen; T Halonen; A Pitkänen
Journal:  Eur J Neurosci       Date:  1996-12       Impact factor: 3.386

Review 5.  Cell and gene therapies in epilepsy--promising avenues or blind alleys?

Authors:  Wolfgang Löscher; Manuela Gernert; Uwe Heinemann
Journal:  Trends Neurosci       Date:  2008-01-16       Impact factor: 13.837

6.  Effect of neural transplants on seizure frequency and kindling in immature rats following kainic acid.

Authors:  G L Holmes; J L Thompson; K Huh; C Holmes; G F Carl
Journal:  Brain Res Dev Brain Res       Date:  1991-12-17

7.  Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Muddanna S Rao; Ashok K Shetty
Journal:  Exp Neurol       Date:  2008-05-15       Impact factor: 5.330

8.  Loss of GABAergic neurons in the subiculum and its functional implications in temporal lobe epilepsy.

Authors:  Andreas Knopp; Christiane Frahm; Pawel Fidzinski; Otto W Witte; Joachim Behr
Journal:  Brain       Date:  2008-05-26       Impact factor: 13.501

9.  Suppression of kindling epileptogenesis in rats by intrahippocampal cholinergic grafts.

Authors:  I Ferencz; M Kokaia; E Elmér; M Keep; Z Kokaia; O Lindvall
Journal:  Eur J Neurosci       Date:  1998-01       Impact factor: 3.386

10.  The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes.

Authors:  Simon J B Butt; Vitor H Sousa; Marc V Fuccillo; Jens Hjerling-Leffler; Goichi Miyoshi; Shioko Kimura; Gord Fishell
Journal:  Neuron       Date:  2008-09-11       Impact factor: 18.688

View more
  2 in total

1.  The fraction of cortical GABAergic neurons is constant from near the start of cortical neurogenesis to adulthood.

Authors:  Setsuko Sahara; Yuchio Yanagawa; Dennis D M O'Leary; Charles F Stevens
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

Review 2.  GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity.

Authors:  Manuel Alvarez Dolado; Vania Broccoli
Journal:  Neural Plast       Date:  2011-06-20       Impact factor: 3.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.